# A Prospective, Longitudinal Study of Caregiver-Reported Adaptive Skills and Function of Individuals with HNRNPH2-related Neurodevelopmental Disorder

**Authors:** Thomas J. Davis, Rachel Salazar, Sarah Beenders, Amelia Boehme, Nicole M. LaMarca, Jennifer M. Bain

PMC · DOI: 10.1007/s41252-023-00346-1 · 2023-08-07

## TL;DR

This study tracks the adaptive skills of individuals with a rare genetic disorder caused by HNRNPH2 mutations, finding consistently low scores compared to peers.

## Contribution

The study provides the first longitudinal analysis of adaptive functioning in individuals with HNRNPH2-related neurodevelopmental disorder.

## Key findings

- Individuals with HNRNPH2-related NDD had mean adaptive scores below the 5th percentile compared to age-matched peers.
- Verbal and ambulatory individuals showed significantly higher PEDI-CAT scores across all domains.
- PEDI-CAT scores remained stable over a 3-year period in a small sample.

## Abstract

This study presents a cohort of individuals in a natural history study with de novo pathogenic missense variants in HNRNPH2 causative of HNRNPH2-related neurodevelopmental disorder (NDD) to describe individuals’ adaptive functional abilities.

We measured adaptive function using the Pediatric Evaluation of Disability Inventory Computer Adaptive Test (PEDI-CAT) and the Vineland Adaptive Behavior Scale (VABS-III). Results were compared using inferential statistics and regression analysis.

Sixty-seven individuals carried known pathogenic or likely pathogenic variants in HNRNPH2. Thirty-five participants (2.89–42.04 years, 83% female) and caregivers completed PEDI-CAT assessments with 25 of these participants completing the VABS-III. Sixteen, three and two participants completed a follow-up PEDI-CAT assessment at one, two and three years respectively. Individuals had mean normative scores less than age-matched peers across all domains on both PEDI-CAT and VABS-III measures, with 91% participants < 5th percentile on both the PEDI- CAT and VABS-III. Verbal and ambulatory participants had significantly higher PEDI-CAT scores across all domains, using both raw and normative data. There was no significant change in PEDI-CAT scores over 3 years.

Overall scores, both raw and normative, are low across all individuals with HNRNPH2-related NDD using both the PEDI-CAT and VABS-III. PEDI-CAT normative scores do not likely represent the clinical variability, but raw scores may be able to capture functional variability. In a small sample, longitudinal data from the PEDI-CAT domain scores demonstrate stability in performance at 3 years.

Trial Registration: ClinicalTrials.gov NCT03492060.

## Linked entities

- **Genes:** HNRNPH2 (heterogeneous nuclear ribonucleoprotein H2) [NCBI Gene 3188]
- **Diseases:** neurodevelopmental disorder (MONDO:0700092)

## Full-text entities

- **Genes:** HNRNPH2 (heterogeneous nuclear ribonucleoprotein H2) [NCBI Gene 3188] {aka FTP3, HNRPH', HNRPH2, MRXSB, NRPH2, hnRNPH'}
- **Diseases:** NDD (MESH:D002658)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11358239/full.md

---
Source: https://tomesphere.com/paper/PMC11358239